CS logo
small CS logo
Bay of Plenty Clinical School

Tauranga, BAY OF Plenty, New Zealand

About Bay of Plenty Clinical School


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Bay of Plenty Clinical School


During the past decade, Bay of Plenty Clinical School conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Bay of Plenty Clinical School


According to Clinical.Site data, the most researched conditions in "Bay of Plenty Clinical School" are "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Bay of Plenty Clinical School" in a lesser frequency.

Clinical Trials Intervention Types at Bay of Plenty Clinical School


Clinical Trials Genders at Bay of Plenty Clinical School


The vast majority of trials in "Bay of Plenty Clinical School" are 2 trials for "All" genders.

Clinical Trials Status at Bay of Plenty Clinical School


Currently, there are NaN active trials in "Bay of Plenty Clinical School". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Bay of Plenty Clinical School, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Bay of Plenty Clinical School, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".